Synthesis and Assay of Vibrio Quorum Sensing Inhibitors
May 31st, 2024
Thiophenesulfonamide compounds are potent and specific inhibitors of Vibrio quorum sensing regulators LuxR/HapR that block their activity in vivo, thus preventing transcription of genes for virulence, motility, and biofilms. This protocol details how these compounds are synthesized, modeled in silico, and assayed in vivo for activity against LuxR/HapR.
Our research focuses on designing, synthesizing, and analyzing potential inhibitors of Vibrio bacteria that cause disease in marine animals and humans. Our previous studies identified thiophene sulfonamide compounds as potent inhibitors of pathogenicity in Vibrio species. We aim to develop compounds for the treatment of Vibrio disease.
We have synthesized a panel of thiophene sulfonamide molecules active against several Vibrio species. We have solved the x-ray crystal structure of a thiophene sulfonamide molecule in the binding pocket of the target Vibrio, and we determined the thiophene sulfonamide mechanism of action in blocking the protein target and preventing pathogenicity in vivo. This protocol is designed with the novice researcher in mind.
Every step was optimized for simplicity and error reduction, while still allowing for teaching concepts and the scientific method. Our protocol bridges microbiology, organic chemistry, structure modeling, and drug design in a novel teaching-based experimental system. Novel therapeutics that target Vibrio bacteria are needed to treat the increasing cases of vibriosis in humans and aquaculture.
Because our compounds are not antibiotics and don't kill cells, they have the potential to treat disease without generating resistance. We will focus on optimizing the inhibitors of Vibrio species that do not have a therapeutically relevant inhibitor yet. We'll also explore the chemical space afforded by substituted aromatic sulfonyl chloride starting materials.
To begin, obtain the lysogeny broth or LB medium and add the antibiotics to the medium. Aliquot five milliliters of the medium into sterile test tubes with caps. Inoculate the media with Escherichia coli strains expressing plasmids taken from freezer stocks and incubate the culture in a shaker overnight.
Next, prepare a 10 millimolar thiophene sulfonamide solution in DMSO and vortex to mix thoroughly. Back dilute the cultures one to 100 times in 10 milliliters of media taken in 15 milliliter conical tubes. Vortex briefly to mix.
Add cultures to the appropriate wells of a 96-well plate. After mixing, prepare a dilution series from rows A to E, transferring 50 microliters of the solution each time. Cover the plate with microporous tape and incubate it.
After removing the tape, using a plate reader, read the optical density at 600 nanometers GFP and mCherry. Finally, record and plot the data as normalized fluorescence per cell. Data for three thiophene sulfonamide compounds suggested that compounds 1A and 3B were each inhibitory to LuxR/HapR to different extents, whereas 2B did not have any activity.
Overview
This study investigates the development of thiophenesulfonamide compounds as inhibitors of Vibrio quorum sensing regulators LuxR/HapR, which are critical for virulence and biofilm formation. The research combines synthetic chemistry with in vivo assays to evaluate the effectiveness of these compounds against Vibrio species.
Key Study Components
Research Area
- Microbiology
- Drug Design
- Pathogen Inhibition
Background
- Vibrio bacteria are significant pathogens affecting both marine animals and humans.
- Thiophenesulfonamide compounds were previously identified as effective inhibitors of Vibrio pathogenicity.
- There is a need for novel therapeutics that target non-antibiotic strategies to prevent resistance.
Methods Used
- Synthesis of thiophenesulfonamide compounds
- Escherichia coli strains as a model to study Vibrio inhibition
- Assays for LuxR/HapR activity using fluorescence measurements
Main Results
- Two compounds (1A and 3B) demonstrated inhibitory effects on LuxR/HapR, while compound 2B showed no activity.
- The mechanism of action involves blocking the target protein to prevent pathogenicity in vivo.
- The study successfully translates complex methodologies into a simpler protocol for teaching purposes.
Conclusions
- This research highlights potential therapeutic options against Vibrio infections without contributing to resistance.
- Successful integration of different scientific disciplines enhances the approach to drug design in microbiology.
